SE0202287D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0202287D0
SE0202287D0 SE0202287A SE0202287A SE0202287D0 SE 0202287 D0 SE0202287 D0 SE 0202287D0 SE 0202287 A SE0202287 A SE 0202287A SE 0202287 A SE0202287 A SE 0202287A SE 0202287 D0 SE0202287 D0 SE 0202287D0
Authority
SE
Sweden
Prior art keywords
compounds
new compounds
preparation
htreceptor
medicament
Prior art date
Application number
SE0202287A
Other languages
Swedish (sv)
Inventor
Bjoern Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0202287A priority Critical patent/SE0202287D0/en
Publication of SE0202287D0 publication Critical patent/SE0202287D0/en
Priority to PCT/SE2003/001102 priority patent/WO2004009586A1/en
Priority to NZ537629A priority patent/NZ537629A/en
Priority to AU2003243101A priority patent/AU2003243101B2/en
Priority to ES03765414T priority patent/ES2281666T3/en
Priority to AT03765414T priority patent/ATE353693T1/en
Priority to PT03765414T priority patent/PT1534391E/en
Priority to DE60311822T priority patent/DE60311822T2/en
Priority to MXPA05000784A priority patent/MXPA05000784A/en
Priority to EP03765414A priority patent/EP1534391B1/en
Priority to JP2004522879A priority patent/JP4831966B2/en
Priority to KR1020057001012A priority patent/KR20050025628A/en
Priority to SI200330754T priority patent/SI1534391T1/en
Priority to BR0312789-3A priority patent/BR0312789A/en
Priority to EA200500235A priority patent/EA007539B1/en
Priority to CA2492924A priority patent/CA2492924C/en
Priority to DK03765414T priority patent/DK1534391T3/en
Priority to CNB038195844A priority patent/CN1305871C/en
Priority to MYPI20032688A priority patent/MY139613A/en
Priority to TW092119594A priority patent/TW200404067A/en
Priority to US10/622,055 priority patent/US7244722B2/en
Priority to AR20030102607A priority patent/AR040605A1/en
Priority to IL16622605A priority patent/IL166226A0/en
Priority to ZA200500205A priority patent/ZA200500205B/en
Priority to NO20050903A priority patent/NO20050903L/en
Priority to HK06100948A priority patent/HK1080859A1/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Compounds of the general formula (I): wherein m, n, R, R, Rand Rare as described in the specification. Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament for the treatment of 5-HTreceptor-related disorders or medical conditions.
SE0202287A 2002-07-19 2002-07-19 New compounds SE0202287D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0202287A SE0202287D0 (en) 2002-07-19 2002-07-19 New compounds
CNB038195844A CN1305871C (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
SI200330754T SI1534391T1 (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
EA200500235A EA007539B1 (en) 2002-07-19 2003-06-25 Novel pyrazinone derivatives for the treatment of 5-htreceptor-related disorders
AU2003243101A AU2003243101B2 (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
ES03765414T ES2281666T3 (en) 2002-07-19 2003-06-25 NOVEDOSOS DERIVED FROM PIPERAZINIL-PIRAZINONA FOR THE TREATMENT OF DISORDERS RELATED TO THE RECEIVER 5-HT2A.
AT03765414T ATE353693T1 (en) 2002-07-19 2003-06-25 NEW PIPERAZINYL-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF 5-HT2A RECEPTOR-RELATED DISEASES
PT03765414T PT1534391E (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
DE60311822T DE60311822T2 (en) 2002-07-19 2003-06-25 NEW PIPERAZINYL-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF 5-HT2A RECEPTOR-RELATED DISEASES
MXPA05000784A MXPA05000784A (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a.
EP03765414A EP1534391B1 (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
JP2004522879A JP4831966B2 (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor related diseases
KR1020057001012A KR20050025628A (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
PCT/SE2003/001102 WO2004009586A1 (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
BR0312789-3A BR0312789A (en) 2002-07-19 2003-06-25 New piperazinyl pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
NZ537629A NZ537629A (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
CA2492924A CA2492924C (en) 2002-07-19 2003-06-25 Novel piperazinone derivates for the treatment of 5-ht2a receptor-related disorders
DK03765414T DK1534391T3 (en) 2002-07-19 2003-06-25 New piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
US10/622,055 US7244722B2 (en) 2002-07-19 2003-07-17 Amino-substituted 1H-pyrazin-2-ones and 1H-quinoxalin-2-ones
MYPI20032688A MY139613A (en) 2002-07-19 2003-07-17 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
TW092119594A TW200404067A (en) 2002-07-19 2003-07-17 New compounds
AR20030102607A AR040605A1 (en) 2002-07-19 2003-07-18 PIPERAZINIL-PIPERAZINONA DERIVATIVES FOR THE TREATMENT OF DISORDERS RELATED TO THE 5-HT2A RECEIVER
IL16622605A IL166226A0 (en) 2002-07-19 2005-01-10 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
ZA200500205A ZA200500205B (en) 2002-07-19 2005-01-10 Novel pierazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
NO20050903A NO20050903L (en) 2002-07-19 2005-02-18 New piperazinyl-pyrazinone derivatives for the treatment of 5HT-2A receptor-related disorders
HK06100948A HK1080859A1 (en) 2002-07-19 2006-01-20 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202287A SE0202287D0 (en) 2002-07-19 2002-07-19 New compounds

Publications (1)

Publication Number Publication Date
SE0202287D0 true SE0202287D0 (en) 2002-07-19

Family

ID=20288606

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202287A SE0202287D0 (en) 2002-07-19 2002-07-19 New compounds

Country Status (5)

Country Link
JP (1) JP4831966B2 (en)
EA (1) EA007539B1 (en)
SE (1) SE0202287D0 (en)
SI (1) SI1534391T1 (en)
ZA (1) ZA200500205B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2412007T3 (en) * 2005-12-21 2013-07-09 Janssen Pharmaceutica, N.V. Novel substituted pyrazinone derivatives for use in diseases mediated by MCH-1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI193974A (en) * 1973-07-13 1975-01-14 Merck & Co Inc
DK143899C (en) * 1975-04-21 1982-04-13 Merck & Co Inc ANALOGY PROCEDURE FOR PREPARATION OF PIPERAZINYLPYRAZINE DERIVATIVES
US4163849A (en) * 1978-03-17 1979-08-07 Merck & Co., Inc. Piperazinylpyrazines
ZA954689B (en) * 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
MXPA01011905A (en) * 1999-05-21 2004-03-19 Biovitrum Ab Novel compounds, their use and preparation.

Also Published As

Publication number Publication date
ZA200500205B (en) 2006-07-26
JP4831966B2 (en) 2011-12-07
SI1534391T1 (en) 2007-06-30
JP2005533847A (en) 2005-11-10
EA200500235A1 (en) 2005-08-25
EA007539B1 (en) 2006-10-27

Similar Documents

Publication Publication Date Title
DK1519724T3 (en) Fredericamycin derivatives as drugs for the treatment of tumors
SE0200920D0 (en) Novel compounds
SE0301700D0 (en) Novel compounds
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
SE0001899D0 (en) New compounds
BRPI0418251B8 (en) phosphonates, monophosphonamidates, bisphosphonamidates, and pharmaceutical composition comprising them
HK1084941A1 (en) Compounds and their use
NO20062335L (en) New diazaspiroalkanes and their use in the treatment of CCR8 mediated diseases
SE0401971D0 (en) Piperidne derivatives
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
GB0112348D0 (en) Compounds
BRPI0412999A (en) Substituted 2-aminotetraline for depression treatment
SE0401345D0 (en) Therapeutic compounds: Pyridine as scaffold
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
SE0401762D0 (en) Novel compounds
SE0401342D0 (en) Therapeutic compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
SE0401970D0 (en) Novel compounds
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
SE0302139D0 (en) Novel compounds
MX2007007027A (en) Piperazinyl pyridine derivatives as anti-obesity agents.
DE602004008959D1 (en) BENZOÄBÜÄ1,4ÜDIOXEPINDERIVATE
UA86776C2 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MY146802A (en) Novel drugs for treating respiratory diseases
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases